Deltasone Related Published Studies
Well-designed clinical trials related to Deltasone (Prednisone)
Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial. [2009.10.05]
Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial. [2009.08.01]
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93. [2009.05.15]
Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 Study. [2009.04.01]
Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. [2009.04]
Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. [2009.03.05]
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. [2009.02]
Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus. [2009.02]
Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. [2009.01]
Efficacy of 1-4 mg per day of prednisone in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled withdrawal clinical trial. [2008.12.15]
Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancer. [2008.11.10]
Combination Therapy of Prednisone and ACE Inhibitor Versus ACE-Inhibitor Therapy Alone in Patients With IgA Nephropathy: A Randomized Controlled Trial. [2008.10.17]
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial. [2008.10.15]
Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma. [2008.10.01]
A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department. [2008.10]
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. [2008.08.28]
A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis. [2008.08.05]
Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group. [2008.07.15]
Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper. [2008.07]
Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. [2008.06]
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized, controlled trial. [2008.05.27]
Prednisone treatment for vestibular neuritis. [2008.04]
Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. [2008.02]
Prednisone vs. placebo in withdrawal therapy following medication overuse headache. [2008.02]
Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. [2008.01.19]
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. [2008.01.10]
Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trial. [2008]
Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone. [2008]
Randomized clinical trial comparing oral prednisone (50 mg) with placebo before laparoscopic cholecystectomy. [2007.12.20]
Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations. [2007.12]
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial. [2007.10.06]
Impact of levetiracetam on mood and cognition during prednisone therapy. [2007.10]
Anti-inflammatory effects of high-dose inhaled fluticasone versush oral prednisone in moderate asthma exacerbations. A randomized clinical trial. [2007.08.09]
Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : randomized phase 2 study of ixabepilone or mitoxantrone and prednisone. [2007.08.01]
The clinical and histopathological effects of prednisone on acute radiation-induced dermatitis in dogs: a placebo-controlled, randomized, double-blind, prospective clinical trial. [2007.08]
Eight versus 16-week re-evaluation period in rheumatoid arthritis patients treated with leflunomide or methotrexate accompanied by moderate dose prednisone. [2007.08]
[Effect of chinese herbs in enhancing prednisone for treatment of refractory rheumatoid arthritis] [2007.08]
Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathy. [2007.07.03]
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. [2007.05.15]
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. [2007.05.01]
Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. [2007.03]
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. [2007.01.23]
Potent potentiating diuretic effects of prednisone in congestive heart failure. [2006.10]
Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation. [2006.10]
Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group. [2006.09.01]
Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial. [2006.08]
Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. [2006.07.25]
Improvement in bronchodilation following deep inspiration after a course of high-dose oral prednisone in asthma. [2006.07]
Effect of two prednisone exposures on mood and declarative memory. [2006.07]
Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone. [2006.06.20]
A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. [2006.05]
Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group. [2006.05]
Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma. [2006.04.01]
Randomized double-blind study with prednisone in Sydenham's chorea. [2006.04]
Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial. [2006.04]
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial. [2006.03.11]
Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi. [2006.03]
Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy. [2006.02.15]
Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19). [2006.02]
Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation. [2006.01.01]
Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. [2006]
Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization. [2006]
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. [2005.12.01]
Randomized, controlled study of inhaled fluticasone propionate, oral administration of prednisone, and environmental management of horses with recurrent airway obstruction. [2005.10]
Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1). [2005.10]
Oral administration of prednisone to control refractory vertigo in Meniere's disease: a pilot study. [2005.09]
Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer. [2005.05.20]
Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone. [2005.05]
Withdrawal of steroids: a randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitis. [2005.05]
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). [2005.03.20]
Adjuvant prednisone therapy in pharyngitis: a randomised controlled trial from general practice. [2005.03]
Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase. [2005.03]
Effects of low-dose prednisone on bone metabolism. [2005.03]
Toxicity in standard melphalan-prednisone therapy among myeloma patients with renal failure--a retrospective analysis and recommendations for dose adjustment. [2005.03]
Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies. [2005.03]
Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial. [2005.01]
Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer. [2005]
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant. [2004.12.15]
Approval summary: Docetaxel in combination with prednisone for the treatment of androgen-independent hormone-refractory prostate cancer. [2004.12.15]
Effect of short-term prednisone use on blood flow, muscle protein metabolism, and function. [2004.12]
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. [2004.10.07]
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. [2004.10.07]
Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. [2004.10.05]
Randomized comparison of dexamethasone combined with melphalan versus melphalan with prednisone in the treatment of elderly patients with multiple myeloma. [2004.10]
The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis. [2004.09.28]
Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. [2004.05]
A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein Purpura [ISRCTN85109383]. [2004.04.02]
[Treatment of functional signs of acute maxillary rhinosinusitis in adults. Efficacy and tolerance of administration of oral prednisone for 3 days] [2004.03.13]
An open-label randomized trial of the safety and efficacy of sirolimus vs. azathioprine in living related renal allograft recipients receiving cyclosporine and prednisone combination. [2004.02]
Treatment of pure membranous lupus nephropathy with prednisone and azathioprine: an open-label trial. [2004.02]
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study. [2003.12]
Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain. [2003.09.01]
A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486). [2003.09]
A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus. [2003.08.15]
Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. [2003.06.26]
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. [2003.05.15]
Randomized, controlled study of the effects of a short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1. [2003.05.01]
Recurrent aphthous stomatitis unresponsive to topical corticosteroids: a study of the comparative therapeutic effects of systemic prednisone and systemic sulodexide. [2003.05]
Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. [2003.04.01]
Glucocorticoid receptor up-regulation in early rheumatoid arthritis treated with low dose prednisone or placebo. [2003.03]
Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: a randomized controlled clinical trial. [2003.03]
|
